Metabolic Reprogramming and GM ‐ CSF Secretion in Areca Nut‐Activated Fibroblasts Drive Oral Precancer Progression
Oral Diseases · 2026-07 · 32 (7) · 1889-1902
DOI: 10.1111/odi.70236 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, online erschienen am 17.02.2026. Verfasst von Yen-Yun Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Dentistry, College of Dental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. Hauptthemen laut MEDLINE: Areca, Fibroblasts, Mouth Neoplasms, Precancerous Conditions. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Science and Technology Council.
Abstract (Originalsprache)
Objective
Oral cancer, with a rising global incidence and poor prognosis, is associated with areca nut use in South and Southeast Asia. In this study, we addressed the effects of areca nut extract (ANE) on oral carcinogenesis by modulating fibroblast behavior in oral tissue.
Methods
Cell viability, migration, invasion, and flow cytometry assays were applied to study cell behaviors. Cytokine array, enzyme‐linked immunosorbent assay, phospho‐kinase array, Western blot analysis, and oxygen consumption and glycolysis assays were performed to evaluate cell functions. Immunohistochemical and immunofluorescent staining using human and hamster oral tissues was applied to validate in vitro findings.
Results
Increased alpha smooth muscle actin (α‐SMA) and fibroblast activation protein (FAP) were observed in fibroblasts from oral precancerous and cancer lesions. ANE increased mitochondrial metabolism in fibroblasts and induced myofibroblast transition. It enhanced epithelial‐to‐mesenchymal transition and granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) secretion in fibroblasts. Conditioned medium from ANE‐treated fibroblasts and recombinant GM‐CSF increased epidermal growth factor receptor (EGFR) phosphorylation and malignant transformation in dysplastic oral keratinocytes. In hamsters, ANE treatment increased GM‐CSF expression in fibroblasts and EGFR phosphorylation in epithelial cells.
Conclusion
ANE promotes epithelial‐to‐mesenchymal transition and GM‐CSF secretion in fibroblasts, which activate EGFR signaling and malignant transformation of oral precancerous cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Dentistry, College of Dental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
- Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
- Drug Development and Value Creation Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan.
- Division of Oral and Maxillofacial Surgery, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
- Division of Oral Pathology & Maxillofacial Radiology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
- Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
ORCID-Profile: Yen-Yun Wang, Shyng-Shiou F Yuan
Förderung
- National Science and Technology Council
Zitieren
APA
Wang, Y. Y., Su, C. W., Tseng, C. H., Chen, P. Y., Nguyen, H. D. H., Chan, L. P., Chen, Y. K., Jiang, S. S., Lo, S., & Yuan, S. F. (2026). Metabolic Reprogramming and GM ‐ CSF Secretion in Areca Nut‐Activated Fibroblasts Drive Oral Precancer Progression. Oral Diseases, 32(7), 1889-1902. https://doi.org/10.1111/odi.70236
Vancouver
Wang YY, Su CW, Tseng CH, Chen PY, Nguyen HDH, Chan LP, et al. Metabolic Reprogramming and GM ‐ CSF Secretion in Areca Nut‐Activated Fibroblasts Drive Oral Precancer Progression. Oral Diseases. 2026;32(7):1889-1902. doi:10.1111/odi.70236
BibTeX
@article{Wang2026,
author = {Wang, Yen-Yun and Su, Chang-Wei and Tseng, Chih-Huang and Chen, Pang-Yu and Nguyen, Hieu D H and Chan, Leong-Perng and Chen, Yuk-Kwan and Jiang, Shih Sheng and Lo, Steven and Yuan, Shyng-Shiou F},
title = {Metabolic Reprogramming and GM ‐ CSF Secretion in Areca Nut‐Activated Fibroblasts Drive Oral Precancer Progression},
journal = {Oral Diseases},
year = {2026},
volume = {32},
number = {7},
pages = {1889--1902},
doi = {10.1111/odi.70236}
}
EUVIMED